LEADER 01451oam  2200385Ka 450 
001 9910695329903321
005 20061101141144.0
035   $a(CKB)5470000002369454
035   $a(OCoLC)73720231
035   $a(EXLCZ)995470000002369454
100   $a20061019d2006      ua             0
101 0 $aeng
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aResearch and development in the pharmaceutical industry$b[electronic resource]
210  1$a[Washington, D.C.] :$cCongress of the U.S., Congressional Budget Office,$d[2006]
215   $avii, 55 pages $cdigital, PDF file
225 1 $aA CBO study
300   $aTitle from title screen (viewed on Oct. 19, 2006).
300   $a"October 2006."
300   $aDistributed to some depository libraries in paper (vii, 55 p. : ill. ; 28 cm.), shipping list no.: 2007-0034-P.
320   $aIncludes bibliographical references.
606   $aPharmaceutical industry$xResearch$zUnited States
606   $aPharmaceutical industry$xTechnological innovations$zUnited States
615  0$aPharmaceutical industry$xResearch
615  0$aPharmaceutical industry$xTechnological innovations
712 02$aUnited States.$bCongressional Budget Office.
801  0$bGPO
801  1$bGPO
801  2$bGPO
906   $aBOOK
912   $a9910695329903321
996   $aResearch and development in the pharmaceutical industry$93190947
997   $aUNINA